Browsing Tag
Inc.
380 posts
Why SailPoint’s Entro deal matters for SAIL stock and enterprise AI governance
SailPoint’s Entro acquisition sharpens SAIL’s AI security story around non-human identities, agentic governance and enterprise credential protection.
Could Martin Marietta’s $13.5bn Lhoist deal reshape the U.S. lime market?
Martin Marietta’s $13.5 billion Lhoist deal expands MLM’s lime, limestone and industrial minerals platform, but leverage and dilution remain key risks.
Micron (NASDAQ: MU) revenue quadruples to $41.5bn as AI memory shortage drives record margins
Micron revenue quadrupled to $41.46 billion as AI memory demand drove record margins and $100 billion in contracts. Read what comes next for $MU now.
Amazon adds $13bn to India AI and cloud investment as AWS capacity race accelerates
Amazon adds $13 billion to its India AI and cloud expansion, raising planned investment to $48 billion. Discover what the AWS push means for the market.
Qualcomm targets $15bn data centre business as Meta anchors AI expansion
Qualcomm targets $15 billion in data centre revenue by 2029 as Meta, Modular and Dragonfly reshape its AI strategy. Read the full analysis now on BNT today.
Why Blackline Safety stock is only C$0.04 above the guaranteed Francisco Partners cash offer
Blackline Safety has secured the final outstanding regulatory approval for its proposed acquisition by Francisco Partners. The deal is now expected to close around June 30, shifting attention from regulatory risk to the company’s ambitious fiscal 2027 recurring-revenue target.
Could AI-guided TMS give NRx a sharper mental health platform story?
NRx’s HOPE Therapeutics begins Zeta-guided TMS treatments, sharpening NRXP’s precision psychiatry, clinic network and depression care strategy.
Why CGTX stock could draw attention after FDA alignment on DLB psychosis
Cognition Therapeutics’ FDA alignment gives zervimesine a clearer DLB psychosis path, sharpening CGTX’s dementia drug development and stock story.
Could elsunersen become the asset that steadies Praxis Precision Medicines’ CNS pipeline?
Find out how Praxis’ FDA Breakthrough Therapy Designation for elsunersen could affect PRAX stock, rare epilepsy strategy and precision neuroscience today!
SK hynix targets $29.4bn Nasdaq raise as AI memory investment accelerates
SK hynix plans a historic $29.4 billion Nasdaq raise to expand AI memory capacity. Discover what the listing means for Nvidia, Micron and Samsung.